Genmab A/S Free Cash Flow
The Free Cash Flow (FCF) of Genmab A/S (GMAB.CO) as of Nov 10, 2026 is 183.03 M USD. In the previous year, Free Cash Flow (FCF) was 1.16 B USD — a change of -84.28% (lower).
Get this data via API
Financial Data API
Free Cash Flow
183.03 MUSD
YoY
-84.28%
Last updated:
The Genmab A/S Free Cash Flow history
3 Years
10 Years
25 Years
Max
| YEAR | Free Cash Flow | YoY |
|---|---|---|
| 183.03 MUSD | -84.28% | |
| 1.16 BUSD | +8.28% | |
| 1.08 BUSD | +94.83% | |
| 551.91 MUSD | +81.93% | |
| 303.36 MUSD | -67.74% | |
| 940.48 MUSD | +404.20% | |
| 186.53 MUSD | +126.08% | |
| 82.51 MUSD | -64.18% | |
| 230.35 MUSD | +409.30% | |
| 45.23 MUSD | +67.33% | |
| 27.03 MUSD | +207.64% | |
| 8.79 MUSD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Genmab A/S Stock analysis
Frequently Asked Questions about Genmab A/S stock
Free Cash Flow (FCF) of Genmab A/S is 183.03 M USD in 2025.
Free Cash Flow (FCF) of Genmab A/S changed from 1.16 B USD to 183.03 M USD, representing a -84.28% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Free Cash Flow (FCF) Genmab A/S since 2006 – with annual values, charts, and detailed analysis.
Free Cash Flow is the cash available after capital expenditures. It represents the cash a company can use for dividends, debt reduction, or reinvestment.
FCF = Operating Cash Flow - Capital Expenditures
Free Cash Flow (FCF)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Free Cash Flow (FCF)'s Genmab A/S historically and in real time.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Cash Flow — Genmab A/S
All Key Metrics — Genmab A/S
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth